|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$22,712,016 |
|
|
Indirect Value
|
$63,973 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-16 |
4 |
AS |
$121.95 |
$504,852 |
D/D |
(4,077) |
104,464 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2016-02-03 |
4 |
AS |
$89.92 |
$548,759 |
D/D |
(6,042) |
115,721 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-12-04 |
4 |
AS |
$123.53 |
$561,748 |
D/D |
(4,531) |
104,464 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-08-03 |
4 |
OE |
$86.52 |
$598,211 |
D/D |
5,803 |
52,555 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-11-05 |
4 |
OE |
$86.52 |
$598,211 |
D/D |
5,803 |
48,305 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-17 |
4 |
D |
$241.50 |
$602,784 |
D/D |
(2,496) |
44,839 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-13 |
4 |
AS |
$151.40 |
$614,001 |
D/D |
(4,044) |
51,657 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-29 |
4 |
AS |
$169.00 |
$626,652 |
D/D |
(3,708) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-11-06 |
4 |
AS |
$148.17 |
$629,723 |
D/D |
(4,250) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-24 |
4 |
D |
$217.57 |
$630,518 |
D/D |
(2,898) |
44,737 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-07 |
4 |
AS |
$152.88 |
$649,740 |
D/D |
(4,250) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-03 |
4 |
AS |
$155.72 |
$661,810 |
D/D |
(4,250) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-10 |
4 |
D |
$214.16 |
$664,110 |
D/D |
(3,101) |
66,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-06 |
4 |
AS |
$238.71 |
$667,253 |
D/D |
(2,787) |
67,563 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-11 |
4 |
AS |
$159.00 |
$675,750 |
D/D |
(4,250) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-22 |
4 |
AS |
$159.00 |
$675,750 |
D/D |
(4,250) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-24 |
4 |
D |
$239.23 |
$693,289 |
D/D |
(2,898) |
38,813 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-21 |
4 |
AS |
$291.01 |
$705,596 |
D/D |
(2,402) |
68,705 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-22 |
4 |
AS |
$291.84 |
$706,679 |
D/D |
(2,401) |
66,304 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-02-10 |
4 |
D |
$237.74 |
$722,730 |
D/D |
(3,040) |
76,438 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-06-01 |
4 |
OE |
$53.74 |
$730,542 |
D/D |
13,594 |
145,061 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-11-04 |
4 |
AS |
$201.62 |
$747,607 |
D/D |
(3,708) |
33,240 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-08-02 |
4 |
AS |
$174.59 |
$756,616 |
D/D |
(4,280) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-18 |
4 |
AS |
$242.08 |
$761,842 |
D/D |
(3,128) |
41,711 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-05 |
4 |
AS |
$122.46 |
$771,622 |
D/D |
(6,264) |
104,748 |
0 |
- |
|
192 Records found
|
|
Page 5 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|